0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Diagnostics Service Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-0R14725
Home | Market Reports | Health| Health Conditions| Cancer
Global Cancer Diagnostics Service Market Research Report 2023
BUY CHAPTERS

Global Cancer Diagnostics Service Market Research Report 2025

Code: QYRE-Auto-0R14725
Report
March 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cancer Diagnostics Service Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cancer Diagnostics Service Market

Cancer Diagnostics Service Market

The global market for Cancer Diagnostics Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cancer Diagnostics Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Diagnostics Service.
The Cancer Diagnostics Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Diagnostics Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Diagnostics Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cancer Diagnostics Service Market Report

Report Metric Details
Report Name Cancer Diagnostics Service Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, Abbott, QIAGEN, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Applied DNA Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cancer Diagnostics Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cancer Diagnostics Service Market report?

Ans: The main players in the Cancer Diagnostics Service Market are Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, Abbott, QIAGEN, Siemens Healthcare GmbH, Thermo Fisher Scientific, Inc., Applied DNA Sciences

What are the Application segmentation covered in the Cancer Diagnostics Service Market report?

Ans: The Applications covered in the Cancer Diagnostics Service Market report are Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, Others

What are the Type segmentation covered in the Cancer Diagnostics Service Market report?

Ans: The Types covered in the Cancer Diagnostics Service Market report are Breast Cancer, Blood Cancer, Lung Cancer, Colorectal Cancer, Ovarian Cancer, Others

Recommended Reports

Cancer Diagnosis

Cancer Therapeutics

Diagnostic Services

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Diagnostics Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Breast Cancer
1.2.3 Blood Cancer
1.2.4 Lung Cancer
1.2.5 Colorectal Cancer
1.2.6 Ovarian Cancer
1.2.7 Others
1.3 Market by Application
1.3.1 Global Cancer Diagnostics Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Diagnostics Service Market Perspective (2020-2031)
2.2 Global Cancer Diagnostics Service Growth Trends by Region
2.2.1 Global Cancer Diagnostics Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Diagnostics Service Historic Market Size by Region (2020-2025)
2.2.3 Cancer Diagnostics Service Forecasted Market Size by Region (2026-2031)
2.3 Cancer Diagnostics Service Market Dynamics
2.3.1 Cancer Diagnostics Service Industry Trends
2.3.2 Cancer Diagnostics Service Market Drivers
2.3.3 Cancer Diagnostics Service Market Challenges
2.3.4 Cancer Diagnostics Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Diagnostics Service Players by Revenue
3.1.1 Global Top Cancer Diagnostics Service Players by Revenue (2020-2025)
3.1.2 Global Cancer Diagnostics Service Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Diagnostics Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Diagnostics Service Revenue
3.4 Global Cancer Diagnostics Service Market Concentration Ratio
3.4.1 Global Cancer Diagnostics Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Diagnostics Service Revenue in 2024
3.5 Global Key Players of Cancer Diagnostics Service Head office and Area Served
3.6 Global Key Players of Cancer Diagnostics Service, Product and Application
3.7 Global Key Players of Cancer Diagnostics Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Diagnostics Service Breakdown Data by Type
4.1 Global Cancer Diagnostics Service Historic Market Size by Type (2020-2025)
4.2 Global Cancer Diagnostics Service Forecasted Market Size by Type (2026-2031)
5 Cancer Diagnostics Service Breakdown Data by Application
5.1 Global Cancer Diagnostics Service Historic Market Size by Application (2020-2025)
5.2 Global Cancer Diagnostics Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Diagnostics Service Market Size (2020-2031)
6.2 North America Cancer Diagnostics Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Diagnostics Service Market Size by Country (2020-2025)
6.4 North America Cancer Diagnostics Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Diagnostics Service Market Size (2020-2031)
7.2 Europe Cancer Diagnostics Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Diagnostics Service Market Size by Country (2020-2025)
7.4 Europe Cancer Diagnostics Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Diagnostics Service Market Size (2020-2031)
8.2 Asia-Pacific Cancer Diagnostics Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Diagnostics Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Diagnostics Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Diagnostics Service Market Size (2020-2031)
9.2 Latin America Cancer Diagnostics Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Diagnostics Service Market Size by Country (2020-2025)
9.4 Latin America Cancer Diagnostics Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Diagnostics Service Market Size (2020-2031)
10.2 Middle East & Africa Cancer Diagnostics Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Diagnostics Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Diagnostics Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Cancer Diagnostics Service Introduction
11.1.4 Illumina Revenue in Cancer Diagnostics Service Business (2020-2025)
11.1.5 Illumina Recent Development
11.2 BGI Genomics Co.,Ltd.
11.2.1 BGI Genomics Co.,Ltd. Company Details
11.2.2 BGI Genomics Co.,Ltd. Business Overview
11.2.3 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Introduction
11.2.4 BGI Genomics Co.,Ltd. Revenue in Cancer Diagnostics Service Business (2020-2025)
11.2.5 BGI Genomics Co.,Ltd. Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Cancer Diagnostics Service Introduction
11.3.4 Agilent Technologies Revenue in Cancer Diagnostics Service Business (2020-2025)
11.3.5 Agilent Technologies Recent Development
11.4 Macrogen
11.4.1 Macrogen Company Details
11.4.2 Macrogen Business Overview
11.4.3 Macrogen Cancer Diagnostics Service Introduction
11.4.4 Macrogen Revenue in Cancer Diagnostics Service Business (2020-2025)
11.4.5 Macrogen Recent Development
11.5 Pacific Biosciences
11.5.1 Pacific Biosciences Company Details
11.5.2 Pacific Biosciences Business Overview
11.5.3 Pacific Biosciences Cancer Diagnostics Service Introduction
11.5.4 Pacific Biosciences Revenue in Cancer Diagnostics Service Business (2020-2025)
11.5.5 Pacific Biosciences Recent Development
11.6 Abbott
11.6.1 Abbott Company Details
11.6.2 Abbott Business Overview
11.6.3 Abbott Cancer Diagnostics Service Introduction
11.6.4 Abbott Revenue in Cancer Diagnostics Service Business (2020-2025)
11.6.5 Abbott Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Details
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Cancer Diagnostics Service Introduction
11.7.4 QIAGEN Revenue in Cancer Diagnostics Service Business (2020-2025)
11.7.5 QIAGEN Recent Development
11.8 Siemens Healthcare GmbH
11.8.1 Siemens Healthcare GmbH Company Details
11.8.2 Siemens Healthcare GmbH Business Overview
11.8.3 Siemens Healthcare GmbH Cancer Diagnostics Service Introduction
11.8.4 Siemens Healthcare GmbH Revenue in Cancer Diagnostics Service Business (2020-2025)
11.8.5 Siemens Healthcare GmbH Recent Development
11.9 Thermo Fisher Scientific, Inc.
11.9.1 Thermo Fisher Scientific, Inc. Company Details
11.9.2 Thermo Fisher Scientific, Inc. Business Overview
11.9.3 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Introduction
11.9.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Diagnostics Service Business (2020-2025)
11.9.5 Thermo Fisher Scientific, Inc. Recent Development
11.10 Applied DNA Sciences
11.10.1 Applied DNA Sciences Company Details
11.10.2 Applied DNA Sciences Business Overview
11.10.3 Applied DNA Sciences Cancer Diagnostics Service Introduction
11.10.4 Applied DNA Sciences Revenue in Cancer Diagnostics Service Business (2020-2025)
11.10.5 Applied DNA Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cancer Diagnostics Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Breast Cancer
 Table 3. Key Players of Blood Cancer
 Table 4. Key Players of Lung Cancer
 Table 5. Key Players of Colorectal Cancer
 Table 6. Key Players of Ovarian Cancer
 Table 7. Key Players of Others
 Table 8. Global Cancer Diagnostics Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Cancer Diagnostics Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Cancer Diagnostics Service Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Cancer Diagnostics Service Market Share by Region (2020-2025)
 Table 12. Global Cancer Diagnostics Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Cancer Diagnostics Service Market Share by Region (2026-2031)
 Table 14. Cancer Diagnostics Service Market Trends
 Table 15. Cancer Diagnostics Service Market Drivers
 Table 16. Cancer Diagnostics Service Market Challenges
 Table 17. Cancer Diagnostics Service Market Restraints
 Table 18. Global Cancer Diagnostics Service Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Cancer Diagnostics Service Market Share by Players (2020-2025)
 Table 20. Global Top Cancer Diagnostics Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics Service as of 2024)
 Table 21. Ranking of Global Top Cancer Diagnostics Service Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Cancer Diagnostics Service Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Cancer Diagnostics Service, Headquarters and Area Served
 Table 24. Global Key Players of Cancer Diagnostics Service, Product and Application
 Table 25. Global Key Players of Cancer Diagnostics Service, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Cancer Diagnostics Service Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Cancer Diagnostics Service Revenue Market Share by Type (2020-2025)
 Table 29. Global Cancer Diagnostics Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Cancer Diagnostics Service Revenue Market Share by Type (2026-2031)
 Table 31. Global Cancer Diagnostics Service Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Cancer Diagnostics Service Revenue Market Share by Application (2020-2025)
 Table 33. Global Cancer Diagnostics Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Cancer Diagnostics Service Revenue Market Share by Application (2026-2031)
 Table 35. North America Cancer Diagnostics Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Cancer Diagnostics Service Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Cancer Diagnostics Service Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Cancer Diagnostics Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Cancer Diagnostics Service Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Cancer Diagnostics Service Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Cancer Diagnostics Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Cancer Diagnostics Service Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Cancer Diagnostics Service Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Cancer Diagnostics Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Cancer Diagnostics Service Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Cancer Diagnostics Service Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Cancer Diagnostics Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Cancer Diagnostics Service Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Cancer Diagnostics Service Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Illumina Company Details
 Table 51. Illumina Business Overview
 Table 52. Illumina Cancer Diagnostics Service Product
 Table 53. Illumina Revenue in Cancer Diagnostics Service Business (2020-2025) & (US$ Million)
 Table 54. Illumina Recent Development
 Table 55. BGI Genomics Co.,Ltd. Company Details
 Table 56. BGI Genomics Co.,Ltd. Business Overview
 Table 57. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product
 Table 58. BGI Genomics Co.,Ltd. Revenue in Cancer Diagnostics Service Business (2020-2025) & (US$ Million)
 Table 59. BGI Genomics Co.,Ltd. Recent Development
 Table 60. Agilent Technologies Company Details
 Table 61. Agilent Technologies Business Overview
 Table 62. Agilent Technologies Cancer Diagnostics Service Product
 Table 63. Agilent Technologies Revenue in Cancer Diagnostics Service Business (2020-2025) & (US$ Million)
 Table 64. Agilent Technologies Recent Development
 Table 65. Macrogen Company Details
 Table 66. Macrogen Business Overview
 Table 67. Macrogen Cancer Diagnostics Service Product
 Table 68. Macrogen Revenue in Cancer Diagnostics Service Business (2020-2025) & (US$ Million)
 Table 69. Macrogen Recent Development
 Table 70. Pacific Biosciences Company Details
 Table 71. Pacific Biosciences Business Overview
 Table 72. Pacific Biosciences Cancer Diagnostics Service Product
 Table 73. Pacific Biosciences Revenue in Cancer Diagnostics Service Business (2020-2025) & (US$ Million)
 Table 74. Pacific Biosciences Recent Development
 Table 75. Abbott Company Details
 Table 76. Abbott Business Overview
 Table 77. Abbott Cancer Diagnostics Service Product
 Table 78. Abbott Revenue in Cancer Diagnostics Service Business (2020-2025) & (US$ Million)
 Table 79. Abbott Recent Development
 Table 80. QIAGEN Company Details
 Table 81. QIAGEN Business Overview
 Table 82. QIAGEN Cancer Diagnostics Service Product
 Table 83. QIAGEN Revenue in Cancer Diagnostics Service Business (2020-2025) & (US$ Million)
 Table 84. QIAGEN Recent Development
 Table 85. Siemens Healthcare GmbH Company Details
 Table 86. Siemens Healthcare GmbH Business Overview
 Table 87. Siemens Healthcare GmbH Cancer Diagnostics Service Product
 Table 88. Siemens Healthcare GmbH Revenue in Cancer Diagnostics Service Business (2020-2025) & (US$ Million)
 Table 89. Siemens Healthcare GmbH Recent Development
 Table 90. Thermo Fisher Scientific, Inc. Company Details
 Table 91. Thermo Fisher Scientific, Inc. Business Overview
 Table 92. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product
 Table 93. Thermo Fisher Scientific, Inc. Revenue in Cancer Diagnostics Service Business (2020-2025) & (US$ Million)
 Table 94. Thermo Fisher Scientific, Inc. Recent Development
 Table 95. Applied DNA Sciences Company Details
 Table 96. Applied DNA Sciences Business Overview
 Table 97. Applied DNA Sciences Cancer Diagnostics Service Product
 Table 98. Applied DNA Sciences Revenue in Cancer Diagnostics Service Business (2020-2025) & (US$ Million)
 Table 99. Applied DNA Sciences Recent Development
 Table 100. Research Programs/Design for This Report
 Table 101. Key Data Information from Secondary Sources
 Table 102. Key Data Information from Primary Sources
 Table 103. Authors List of This Report


List of Figures
 Figure 1. Cancer Diagnostics Service Picture
 Figure 2. Global Cancer Diagnostics Service Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cancer Diagnostics Service Market Share by Type: 2024 VS 2031
 Figure 4. Breast Cancer Features
 Figure 5. Blood Cancer Features
 Figure 6. Lung Cancer Features
 Figure 7. Colorectal Cancer Features
 Figure 8. Ovarian Cancer Features
 Figure 9. Others Features
 Figure 10. Global Cancer Diagnostics Service Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Cancer Diagnostics Service Market Share by Application: 2024 VS 2031
 Figure 12. Hospitals Case Studies
 Figure 13. Ambulatory Surgical Centers Case Studies
 Figure 14. Diagnostic Laboratories Case Studies
 Figure 15. Others Case Studies
 Figure 16. Cancer Diagnostics Service Report Years Considered
 Figure 17. Global Cancer Diagnostics Service Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Cancer Diagnostics Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Cancer Diagnostics Service Market Share by Region: 2024 VS 2031
 Figure 20. Global Cancer Diagnostics Service Market Share by Players in 2024
 Figure 21. Global Top Cancer Diagnostics Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics Service as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Cancer Diagnostics Service Revenue in 2024
 Figure 23. North America Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Cancer Diagnostics Service Market Share by Country (2020-2031)
 Figure 25. United States Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Cancer Diagnostics Service Market Share by Country (2020-2031)
 Figure 29. Germany Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Cancer Diagnostics Service Market Share by Region (2020-2031)
 Figure 37. China Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Cancer Diagnostics Service Market Share by Country (2020-2031)
 Figure 45. Mexico Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Cancer Diagnostics Service Market Share by Country (2020-2031)
 Figure 49. Turkey Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Cancer Diagnostics Service Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Illumina Revenue Growth Rate in Cancer Diagnostics Service Business (2020-2025)
 Figure 53. BGI Genomics Co.,Ltd. Revenue Growth Rate in Cancer Diagnostics Service Business (2020-2025)
 Figure 54. Agilent Technologies Revenue Growth Rate in Cancer Diagnostics Service Business (2020-2025)
 Figure 55. Macrogen Revenue Growth Rate in Cancer Diagnostics Service Business (2020-2025)
 Figure 56. Pacific Biosciences Revenue Growth Rate in Cancer Diagnostics Service Business (2020-2025)
 Figure 57. Abbott Revenue Growth Rate in Cancer Diagnostics Service Business (2020-2025)
 Figure 58. QIAGEN Revenue Growth Rate in Cancer Diagnostics Service Business (2020-2025)
 Figure 59. Siemens Healthcare GmbH Revenue Growth Rate in Cancer Diagnostics Service Business (2020-2025)
 Figure 60. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Diagnostics Service Business (2020-2025)
 Figure 61. Applied DNA Sciences Revenue Growth Rate in Cancer Diagnostics Service Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS